(Reuters) – Switzerland’s Novartis AG is preparing to auction its U.S. generic pill business, looking to shed a unit that has struggled amid fierce price competition, people familiar with the matter said on Friday.
Source: Reuters Medical News
Michael Macdonnell, national director of health system transformation at NHS England, discusses integrated care and building on the work from the vanguard programme
Related items from OnMedica How vanguards are increasing healthy life expectancy in Nottinghamshire |
Source: OnMedica